{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:00:14Z","timestamp":1785495614553,"version":"3.56.0"},"reference-count":34,"publisher":"Pleiades Publishing Ltd","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochemistry Moscow"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1134\/s0006297926601206","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T10:27:45Z","timestamp":1785493665000},"page":"1276-1286","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Monitoring Early Efficacy of the Checkpoint Immunotherapy Based on Fluorescence Lifetime Imaging Microscopy of the Patient-Derived Lymphocyte Subsets"],"prefix":"10.1134","volume":"91","author":[{"given":"Diana V.","family":"Yuzhakova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia I.","family":"Kononova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna V.","family":"Izosimova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita M.","family":"Sazhina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya D.","family":"Shchechkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artem M.","family":"Mozherov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel A.","family":"Bureev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry A.","family":"Kuzmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena I.","family":"Gavrina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina S.","family":"Shumskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey V.","family":"Gamayunov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina V.","family":"Shirmanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"137","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"3072_CR1","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/j.cell.2023.03.006","volume":"186","author":"P. Sharma","year":"2023","unstructured":"Sharma, P., Goswami, S., Raychaudhuri, D., Siddiqui, B. A., Singh, P., Nagarajan, A., Liu, J., Subudhi, S. K., Poon, C., Gant, K. L., Herbrich, S. M., Anandhan, S., Islam, S., Amit, M., Anandappa, G., and Allison, J. P. (2023) Immune checkpoint therapy-current perspectives and future directions, Cell, 186, 1652-1669, \nhttps:\/\/doi.org\/10.1016\/j.cell.2023.03.006.","journal-title":"Cell"},{"key":"3072_CR2","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41571-022-00600-w","volume":"19","author":"D. B. Johnson","year":"2022","unstructured":"Johnson, D. B., Nebhan, C. A., Moslehi, J. J., and Balko, J. M. (2022) Immune-checkpoint inhibitors: long-term implications of toxicity, Nat. Rev. Clin. Oncol., 19, 254-267, \nhttps:\/\/doi.org\/10.1038\/s41571-022-00600-w.","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"3072_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23147839","volume":"23","author":"J. Y. Lee","year":"2022","unstructured":"Lee, J. Y., Kannan, B., Lim, B. Y., Li, Z., Lim, A. H., Loh, J. W., Ko, T. K., Ng, C. C.-Y., and Chan, J. Y. (2022) The multi-dimensional biomarker landscape in cancer immunotherapy, Int. J. Mol. Sci., 23, 7839, \nhttps:\/\/doi.org\/10.3390\/ijms23147839.","journal-title":"Int. J. Mol. Sci."},{"key":"3072_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15233054","volume":"15","author":"F. Venturi","year":"2025","unstructured":"Venturi, F., Magnaterra, E., Gualandi, A., Scotti, B., Baraldi, C., Alessandrini, A. M., Veneziano, L., Cama, E. M., Melotti, B., Marchese, P. V., Tassone, D., Ribero, S., Ardig\u00f2, M., and Dika, E. (2025) Toward personalized response monitoring in melanoma patients treated with immunotherapy and target therapy, Diagnostics (Basel), 15, 3054, \nhttps:\/\/doi.org\/10.3390\/diagnostics15233054.","journal-title":"Diagnostics (Basel)"},{"key":"3072_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.387","volume":"4","author":"X. Lin","year":"2023","unstructured":"Lin, X., Zong, C., Zhang, Z., Fang, W., and Xu, P. (2023) Progresses in biomarkers for cancer immunotherapy, MedComm, 4, e387, \nhttps:\/\/doi.org\/10.1002\/mco2.387.","journal-title":"MedComm"},{"key":"3072_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-012606","volume":"13","author":"A. Hanna","year":"2025","unstructured":"Hanna, A., Sun, X., Sheng, Q., Gonzalez-Ericsson, P. I., Wescott, E. C., Taylor, B. C., Marshall, J. L., Opalenik, S. R., Toren, A. L., Sanchez, V., Fielder, C. M., Sanders, M. E., and Balko, J. M. (2025) Monitoring systemic immune responses to checkpoint inhibition in breast cancer reveals host responses and mechanisms of resistance, J.\u00a0Immunother. Cancer, 13, e012606, \nhttps:\/\/doi.org\/10.1136\/jitc-2025-012606.","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"3072_CR7","doi-asserted-by":"publisher","first-page":"335","DOI":"10.32604\/oncologie.2021.018610","volume":"23","author":"S. Ganesh","year":"2021","unstructured":"Ganesh, S., Wang, R., and Chen, H. (2021) Dynamic monitoring of immunotherapy effectiveness with different biomarkers in the patients with non-small cell lung cancer, Oncologie, 23, 335-350, \nhttps:\/\/doi.org\/10.32604\/oncologie.2021.018610.","journal-title":"Oncologie"},{"key":"3072_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1507938","volume":"15","author":"E. Sosa Cuevas","year":"2024","unstructured":"Sosa Cuevas, E., Mouret, S., Vayssi\u00e8re, G., Kerboua, S., Girard, P., Molens, J.-P., Manceau, M., Charles, J., Saas, P., and Aspord, C. (2024) Circulating immune landscape in melanoma patients undergoing anti-PD1 therapy reveals key immune features according to clinical response to treatment, Front. Immunol., 15, 1507938, \nhttps:\/\/doi.org\/10.3389\/fimmu.2024.1507938.","journal-title":"Front. Immunol."},{"key":"3072_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01549-2","volume":"18","author":"X. Zhou","year":"2020","unstructured":"Zhou, X., Yao, Z., Yang, H., Liang, N., Zhang, X., and Zhang, F. (2020) Are immune-related adverse events associated with the efficacy of immune checkpoint inhibitors in patients with cancer? A systematic review and meta-analysis, BMC Med., 18, 87, \nhttps:\/\/doi.org\/10.1186\/s12916-020-01549-2.","journal-title":"BMC Med."},{"key":"3072_CR10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cca.2022.06.001","volume":"533","author":"L. A. Rozeman","year":"2022","unstructured":"Rozeman, L. A., Versluis, J. M., Moritz, R., Wilgenhof, S., van Thienen, J. V., Haanen, J. B. A. G., van de Heuvel, M. M., Blank, C. U., and van Rossum, H. H. (2022) Diagnostic performance of early increase in S100B or LDH as outcome predictor for non-responsiveness to anti-PD-1 monotherapy in advanced melanoma, Clin. Chim. Acta, 533, 71-78, \nhttps:\/\/doi.org\/10.1016\/j.cca.2022.06.001.","journal-title":"Clin. Chim. Acta"},{"key":"3072_CR11","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/s41568-020-0273-y","volume":"20","author":"R. D. Leone","year":"2020","unstructured":"Leone, R. D., and Powell, J. D. (2020) Metabolism of immune cells in cancer, Nat. Rev. Cancer, 20, 516-531, \nhttps:\/\/doi.org\/10.1038\/s41568-020-0273-y.","journal-title":"Nat. Rev. Cancer"},{"key":"3072_CR12","doi-asserted-by":"publisher","DOI":"10.20900\/immunometab20200020","volume":"2","author":"H.-I. Aksoylar","year":"2020","unstructured":"Aksoylar, H.-I., Tijaro-Ovalle, N. M., Boussiotis, V. A., and Patsoukis, N. (2020) T cell metabolism in cancer immunotherapy, Immunometabolism, 2, e200020, \nhttps:\/\/doi.org\/10.20900\/immunometab20200020.","journal-title":"Immunometabolism"},{"key":"3072_CR13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s41423-024-01148-8","volume":"21","author":"S. Ma","year":"2024","unstructured":"Ma, S., Ming, Y., Wu, J., and Cui, G. (2024) Cellular metabolism regulates the differentiation and function of T-cell subsets, Cell Mol. Immunol., 21, 419-435, \nhttps:\/\/doi.org\/10.1038\/s41423-024-01148-8.","journal-title":"Cell Mol. Immunol."},{"key":"3072_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41417-020-0183-x","volume":"28","author":"R. E. Tay","year":"2021","unstructured":"Tay, R. E., Richardson, E. K., and Toh, H. C. (2021) Revisiting the role of CD4+ T cells in cancer immunotherapy-new insights into old paradigms, Cancer Gene Ther., 28, 5-17, \nhttps:\/\/doi.org\/10.1038\/s41417-020-0183-x.","journal-title":"Cancer Gene Ther."},{"key":"3072_CR15","doi-asserted-by":"publisher","DOI":"10.1117\/1.JBO.25.7.071203","volume":"25","author":"R. Datta","year":"2020","unstructured":"Datta, R., Heaster, T. M., Sharick, J. T., Gillette, A. A., and Skala, M. C. (2020) Fluorescence lifetime imaging microscopy: fundamentals and advances in instrumentation, analysis, and applications, J. Biomed. Opt., 25, 071203, \nhttps:\/\/doi.org\/10.1117\/1.JBO.25.7.071203.","journal-title":"J. Biomed. Opt."},{"key":"3072_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/jbio.202400450","volume":"18","author":"V. I. Shcheslavskiy","year":"2025","unstructured":"Shcheslavskiy, V. I., Shirmanova, M. V., Yashin, K. S., R\u00fcck, A. C., Skala, M. C., and Becker, W. (2025) Fluorescence lifetime imaging techniques \u2013 a review on principles, applications and clinical relevance, J.\u00a0Biophotonics, 18, e202400450, \nhttps:\/\/doi.org\/10.1002\/jbio.202400450.","journal-title":"J.\u00a0Biophotonics"},{"key":"3072_CR17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41551-020-0592-z","volume":"5","author":"A. J. Walsh","year":"2021","unstructured":"Walsh, A. J., Mueller, K. P., Tweed, K., Jones, I., Walsh, C. M., Piscopo, N. J., Niemi, N. M., Pagliarini, D. J., Saha, K., and Skala, M. C. (2021) Classification of T-cell activation via autofluorescence lifetime imaging, Nat. Biomed. Eng., 5, 77-88, \nhttps:\/\/doi.org\/10.1038\/s41551-020-0592-z.","journal-title":"Nat. Biomed. Eng."},{"key":"3072_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2021.644648","volume":"9","author":"T. M. Heaster","year":"2021","unstructured":"Heaster, T. M., Heaton, A. R., Sondel, P. M., and Skala, M. C. (2021) Intravital metabolic autofluorescence imaging captures macrophage heterogeneity across normal and cancerous tissue, Front. Bioeng. Biotechnol., 9, 644648, \nhttps:\/\/doi.org\/10.3389\/fbioe.2021.644648.","journal-title":"Front. Bioeng. Biotechnol."},{"key":"3072_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232415829","volume":"23","author":"A. V. Izosimova","year":"2022","unstructured":"Izosimova, A. V., Shirmanova, M. V., Shcheslavskiy, V. I., Sachkova, D. A., Mozherov, A. M., Sharonov, G. V., Zagaynova, E. V., and Yuzhakova, D. V. (2022) FLIM of NAD(P)H in lymphatic nodes resolves T-cell immune response to the tumor, Int. J. Mol. Sci., 23, 15829, \nhttps:\/\/doi.org\/10.3390\/ijms232415829.","journal-title":"Int. J. Mol. Sci."},{"key":"3072_CR20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.17691\/stm2023.15.3.01","volume":"15","author":"A. V. Izosimova","year":"2023","unstructured":"Izosimova, A. V., Mozherov, A. M., Shirmanova, M. V., Shcheslavskiy, V. I., Sachkova, D. A., Zagaynova, E. V., Sharonov, G. V., and Yuzhakova, D. V. (2023) Fluorescence lifetime imaging of NAD(P)H T cells autofluorescence in the lymphatic nodes to assess the effectiveness of Anti-CTLA-4 immunotherapy [in Russian], Sovrem. Tekhnol. Med., 15, 5-15, \nhttps:\/\/doi.org\/10.17691\/stm2023.15.3.01.","journal-title":"Sovrem. Tekhnol. Med."},{"key":"3072_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/cells14020097","volume":"14","author":"D. V. Yuzhakova","year":"2025","unstructured":"Yuzhakova, D. V., Sachkova, D. A., Izosimova, A. V., Yashin, K. S., Yusubalieva, G. M., Baklaushev, V. P., Mozherov, A. M., Shcheslavskiy, V. I., and Shirmanova, M. V. (2025) Fluorescence lifetime imaging of NAD(P)H in patients\u2019 lymphocytes: evaluation of efficacy of immunotherapy, Cells, 14, 97, \nhttps:\/\/doi.org\/10.3390\/cells14020097.","journal-title":"Cells"},{"key":"3072_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ph16060796","volume":"16","author":"D. V. Yuzhakova","year":"2023","unstructured":"Yuzhakova, D. V., Sachkova, D. A., Shirmanova, M. V., Mozherov, A. M., Izosimova, A. V., Zolotova, A. S., and Yashin, K. S. (2023) Measurement of patient-derived glioblastoma cell response to temozolomide using fluorescence lifetime imaging of NAD(P)H, Pharmaceuticals (Basel), 16, 796, \nhttps:\/\/doi.org\/10.3390\/ph16060796.","journal-title":"Pharmaceuticals (Basel)"},{"key":"3072_CR23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.immuni.2005.01.016","volume":"22","author":"J. D. Fontenot","year":"2005","unstructured":"Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G., and Rudensky, A. Y. (2005) Regulatory T cell lineage specification by the forkhead transcription factor foxp3, Immunity, 22, 329-341, \nhttps:\/\/doi.org\/10.1016\/j.immuni.2005.01.016.","journal-title":"Immunity"},{"key":"3072_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20225565","volume":"20","author":"R. Leben","year":"2019","unstructured":"Leben, R., K\u00f6hler, M., Radbruch, H., Hauser, A. E., and Niesner, R. A. (2019) Systematic enzyme mapping of cellular metabolism by phasor-analyzed label-free NAD(P)H fluorescence lifetime imaging, Int. J. Mol. Sci., 20, 5565, \nhttps:\/\/doi.org\/10.3390\/ijms20225565.","journal-title":"Int. J. Mol. Sci."},{"key":"3072_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-23691-x","volume":"8","author":"J. T. Sharick","year":"2018","unstructured":"Sharick, J. T., Favreau, P. F., Gillette, A. A., Sdao, S. M., Merrins, M. J., and Skala, M. C. (2018) Protein-bound NAD(P)H lifetime is sensitive to multiple fates of glucose carbon, Sci. Rep., 8, 5456, \nhttps:\/\/doi.org\/10.1038\/s41598-018-23691-x.","journal-title":"Sci. Rep."},{"key":"3072_CR26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2118241119","volume":"119","author":"E. A. Shirshin","year":"2022","unstructured":"Shirshin, E. A., Shirmanova, M. V., Gayer, A. V., Lukina, M. M., Nikonova, E. E., Yakimov, B. P., Budylin, G. S., Dudenkova, V. V., Ignatova, N. I., Komarov, D. V., et\u00a0al. (2022) Label-free sensing of cells with fluorescence lifetime imaging: the quest for metabolic heterogeneity, Proc. Natl. Acad. Sci. USA, 119, e2118241119, \nhttps:\/\/doi.org\/10.1073\/pnas.2118241119.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"3072_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-024-06123-7","volume":"7","author":"A. Song","year":"2024","unstructured":"Song, A., Zhao, N., Hilpert, D. C., Perry, C., Baur, J. A., Wallace, D. C., and Schaefer, P. M. (2024) Visualizing subcellular changes in the NAD(H) pool size versus redox state using fluorescence lifetime imaging microscopy of NADH, Commun. Biol., 7, 428, \nhttps:\/\/doi.org\/10.1038\/s42003-024-06123-7.","journal-title":"Commun. Biol."},{"key":"3072_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109516","volume":"36","author":"Y. Wang","year":"2021","unstructured":"Wang, Y., Wang, F., Wang, L., Qiu, S., Yao, Y., Yan, C., Xiong, X., Chen, X., Ji, Q., Cao, J., Gao, G., Li, D., Zhang, L., Guo, Z., Wang, R., Wang, H., and Fan, G. (2021) NAD+ supplement potentiates tumor-killing function by rescuing defective TUB-mediated NAMPT transcription in tumor-infiltrated T cells, Cell Rep., 36, 109516, \nhttps:\/\/doi.org\/10.1016\/j.celrep.2021.109516.","journal-title":"Cell Rep."},{"key":"3072_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70566","volume":"7","author":"Y. Fu","year":"2026","unstructured":"Fu, Y., Liu, J., Mo, Z., Wang, B., Deng, Y., and Jiang, Y. (2026) Melanoma: pathogenesis and targeted therapy, MedComm, 7, e70566, \nhttps:\/\/doi.org\/10.1002\/mco2.70566.","journal-title":"MedComm"},{"key":"3072_CR30","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41577-025-01222-w","volume":"26","author":"F. Fallarino","year":"2026","unstructured":"Fallarino, F., and Blank, C. U. (2026) Lessons from neoadjuvant immunotherapy in melanoma: understanding antitumour immunity and tumour escape, Nat. Rev. Immunol., 26, 152-162, \nhttps:\/\/doi.org\/10.1038\/s41577-025-01222-w.","journal-title":"Nat. Rev. Immunol."},{"key":"3072_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26094394","volume":"26","author":"J. A. Awosika","year":"2025","unstructured":"Awosika, J. A., Gulley, J. L., and Pastor, D. M. (2025) Deficient mismatch repair and microsatellite instability in solid tumors, Int. J. Mol. Sci., 26, 4394, \nhttps:\/\/doi.org\/10.3390\/ijms26094394.","journal-title":"Int. J. Mol. Sci."},{"key":"3072_CR32","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ccell.2020.10.001","volume":"39","author":"D. L. Jardim","year":"2021","unstructured":"Jardim, D. L., Goodman, A., de Melo Gagliato, D., and Kurzrock, R. (2021) The challenges of tumor mutational burden as an immunotherapy biomarker, Cancer Cell, 39, 154-173, \nhttps:\/\/doi.org\/10.1016\/j.ccell.2020.10.001.","journal-title":"Cancer Cell"},{"key":"3072_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1006665","volume":"13","author":"G. Georgoulias","year":"2022","unstructured":"Georgoulias, G., and Zaravinos, A. (2022) Genomic landscape of the immunogenicity regulation in skin melanomas with diverse tumor mutation burden, Front. Immunol., 13, 1006665, \nhttps:\/\/doi.org\/10.3389\/fimmu.2022.1006665.","journal-title":"Front. Immunol."},{"key":"3072_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-026-01287-3","volume":"10","author":"D. Nishizaki","year":"2026","unstructured":"Nishizaki, D., Law, A., Li, B., Abbott, C., Chen, Y., Lee, S., Pyke, R., Keough, K., Daniels, G. A., Yeung, K. T., Boyle, S. M., Chen, R. O., and Kato, S. (2026) Ultrasensitive ctDNA monitoring reveals early predictors of immunotherapy response in advanced cancer, NPJ Precis Oncol., 10, 79, \nhttps:\/\/doi.org\/10.1038\/s41698-026-01287-3.","journal-title":"NPJ Precis Oncol."}],"container-title":["Biochemistry (Moscow)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297926601206.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1134\/S0006297926601206","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297926601206.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T10:27:46Z","timestamp":1785493666000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1134\/S0006297926601206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["3072"],"URL":"https:\/\/doi.org\/10.1134\/s0006297926601206","relation":{},"ISSN":["0006-2979","1608-3040"],"issn-type":[{"value":"0006-2979","type":"print"},{"value":"1608-3040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"16 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval and consent to participate.\n                      All animal studies and research involving patient\u2010derived biomaterials were conducted in accordance with the Declaration of Helsinki and were approved by the Local Ethics Committee of the Privolzhsky Research Medical University (Nizhny Novgorod, Russia) (protocol no.\u00a09, dated June 30, 2023). All participants provided informed written consent prior to their inclusion in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}},{"value":"Conflict of interest.\n                      The authors of this work declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}]}}